92 results on '"May T"'
Search Results
2. Malignant melanoma of the vulva and vagina: A study of 1863 cases
3. Risk stratification using hotspot genotyping in low-grade serous ovarian cancer
4. Cost-effectiveness of maintenance hormonal therapy in patients with advanced low-grade serous ovarian cancer
5. Oncologic outcomes and morbidity following heated intraperitoneal chemotherapy at cytoreductive surgery for primary epithelial ovarian cancer: A systematic review and meta-analysis
6. Does timing of intraperitoneal chemotherapy initiation following bowel resection in patients with newly diagnosed advanced ovarian cancer impact short- and long-term outcomes?
7. Evaluation of a systematic gynecologic oncology fellowship education curriculum
8. Survival after minimally invasive surgery in early cervical cancer: Is the uterine manipulator to blame?
9. The use of indocyanine green fluorescence angiography for colorectal anastomoses in cytoreductive surgery for ovarian carcinoma
10. Creating a scoring system using pre-operative factors to predict the extent of surgery at the time of interval cytoreduction in advanced ovarian cancer
11. Resuming chemotherapy after interval cytoreductive surgery in ovarian cancer: The impact of time and temperature
12. CA-125 levels are predictive of survival in women with low grade serous ovarian carcinoma
13. Prospective validation of sentinel lymph node (SLN) biopsy with indocyanine green (ICG) fluorescence imaging in high-risk endometrial cancer
14. Investigating the time intervals between primary cytoreductive surgery and initiation of adjuvant chemotherapy in patients with advanced epithelial ovarian cancer who had optimal cytoreduction surgery with bowel resection
15. Does the time interval off neoadjuvant chemotherapy before and after interval debulking surgery affect the overall survival of women with advanced-epithelial ovarian cancer?
16. The feasibility of minimally invasive radical trachelectomy in children with embryonal rhabdomyosarcoma of the cervix: Improving surgical quality and recovery in this pediatric population
17. Investigating the impact of interval from primary debulking surgery to initiation of adjuvant chemotherapy in advanced high-grade serous ovarian cancer
18. Neoadjuvant chemotherapy and cycle number: A national multicentre study
19. Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage endometrioid adenocarcinoma of the uterus
20. Clinical behavior of low grade serous ovarian carcinoma: Ananalysis of 714 patients from the Ovarian Cancer Association Consortium (OCAC)
21. Examining selection for resistant clones in high-grade serous ovarian cancer after neoadjuvant chemotherapy
22. Does the initial management of high-grade serous ovarian cancer predict recurrence?
23. Surgical factors do not impact survival in high-grade serous ovarian carcinoma patients treated with neoadjuvant chemotherapy
24. Clinical behavior of low grade serous ovarian carcinoma: An analysis of 714 patients from the Ovarian Cancer Association Consortium (OCAC)
25. Do updated Pap smear screening guidelines prevent the expeditious diagnosis of invasive cervical cancer?
26. The effectiveness of intraperitoneal chemotherapy in treating retroperitoneal stage IIIC ovarian carcinoma
27. Multi-center gene expression analysis of Mullerian low-grade and high-grade serous carcinoma highlights genes potentially involved in chemotherapy resistance
28. BRCA1 expression is suppressed in sporadic ovarian cancer cells by overexpression of C-terminal binding protein-2
29. Can we safely omit paraaortic lymphadenectomy from the surgical staging of high-grade endometrioid, clear cell and papillary serous endometrial adenocarcinoma?
30. Surgical factors do not impact survival in high-grade serous ovarian carcinoma patients treated with neoadjuvant chemotherapy
31. Do updated Pap smear screening guidelines prevent the expeditious diagnosis of invasive cervical cancer?
32. Correlating the KELIM (CA125 elimination rate constant K) score and the chemo-response score as predictors of chemosensitivity in patients with advanced ovarian carcinoma.
33. Robotic versus vaginal radical trachelectomy for reproductive-aged patients with early-stage cervical carcinoma: A multi-center cohort study.
34. Validation of the KELIM score as a predictor of response to neoadjuvant treatment in patients with advanced high grade serous ovarian cancer.
35. Integrated prediction model of patient factors, resectability scores and surgical complexity to predict cytoreductive outcome and guide treatment plan in advanced ovarian cancer.
36. Secondary cytoreductive surgery for recurrent low-grade serous ovarian carcinoma: A systematic review and meta-analysis.
37. Hormone maintenance therapy for women with low-grade serous ovarian cancer in the front-line setting: A systematic review.
38. The correlation between BRCA status and surgical cytoreduction in high-grade serous ovarian carcinoma.
39. Factors associated with an increased risk of recurrence in patients diagnosed with high-grade endometrial cancer undergoing minimally invasive surgery: A study of the society of gynecologic oncology of Canada (GOC) community of practice (CoP).
40. The Prevent Ovarian Cancer Program (POCP): Identification of women at risk for ovarian cancer using complementary recruitment approaches.
41. Gynecologic oncology treatment modifications or delays in response to the COVID-19 pandemic in a publicly funded versus privately funded North American tertiary cancer center.
42. Cost-effectiveness of maintenance hormonal therapy in patients with advanced low grade serous ovarian cancer.
43. Evaluating the diagnostic performance of preoperative endometrial biopsies in patients diagnosed with high grade endometrial cancer: A study of the Society of Gynecologic Oncology (GOC) Community of Practice (CoP).
44. Does timing of intraperitoneal chemotherapy initiation following primary cytoreductive surgery with bowel resection impact outcomes in patients with advanced ovarian cancer?
45. The use of indocyanine green fluorescence angiography to assess anastomotic perfusion following bowel resection in surgery for gynecologic malignancies - A report of 100 consecutive anastomoses.
46. Low-grade serous ovarian cancer: State of the science.
47. Neoadjuvant chemotherapy and chemotherapy cycle number: A national multicentre study.
48. Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation status.
49. Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary.
50. Changes in clinical presentation of postterm choriocarcinoma at the New England Trophoblastic Disease Center in recent years.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.